Start for free
Start for free
SC

StemPoint Capital

North America, New York, United States, New York

Description

StemPoint looks to exploit the growing characteristics of the biotechnology sector and the protective attributes of the pharmaceutical.

Investor Profile

StemPoint Capital has made 8 investments, with 2 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (88%)
  • Switzerland (13%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Emergency Medicine
  • Pharmaceutical
  • Clinical Trials
  • Biopharma
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does StemPoint Capital frequently co-invest with?

AC
Acuta Capital Partners
North America, California, United States, Belmont
Co-Investments: 2
Woodline Partners
Woodline Partners
North America, California, United States, San Francisco
Co-Investments: 3
Braidwell
Braidwell
North America, Connecticut, United States, Stamford
Co-Investments: 2
Avidity Partners
Avidity Partners
North America, Texas, United States, Dallas
Co-Investments: 2
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 5
Ally Bridge Group
Ally Bridge Group
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 2
Great Point Partners
Great Point Partners
North America, Connecticut, United States, Greenwich
Co-Investments: 2
Deep Track Capital
Deep Track Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 3
Vivo Capital
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Logos Capital
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 2

What are some of recent deals done by StemPoint Capital?

Surrozen

South San Francisco, California, United States

Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.

BiotechnologyEmergency MedicineHealth Care
Post Ipo EquityMar 24, 2025
Amount Raised: $175,000,000
Tectonic Therapeutic

Allston, Massachusetts, United States

Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.

Biotechnology
Post Ipo EquityFeb 3, 2025
Amount Raised: $185,000,000
Protara Therapeutics

New York, New York, United States

Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityApr 5, 2024
Amount Raised: $45,000,000
Surrozen

South San Francisco, California, United States

Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.

BiotechnologyEmergency MedicineHealth Care
Post Ipo EquityApr 1, 2024
Amount Raised: $17,500,000
Pyxis Oncology

Boston, Massachusetts, United States

Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.

BiotechnologyHealth CareOncologyPharmaceutical
Post Ipo EquityFeb 27, 2024
Amount Raised: $50,000,000
Dianthus Therapeutics

Waltham, Massachusetts, United States

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

BiopharmaBiotechnologyHealth Care
Post Ipo EquityJan 22, 2024
Amount Raised: $230,000,000
AC Immune

Lausanne, Vaud, Switzerland

AC Immune is a biopharmaceutical company focused on neurodegenerative diseases with three product candidates in clinical trials

BiotechnologyPharmaceuticalTherapeutics
Post Ipo EquityDec 15, 2023
Amount Raised: $50,050,000
Tourmaline Bio

New York, New York, United States

Tourmaline Bio is a clinical biotechnology company developing transformative medicines to dramatically improve and prevent immune diseases.

BiotechnologyClinical TrialsTherapeutics
Post Ipo EquityOct 19, 2023
Amount Raised: $75,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator